NASDAQ:CDT CDT Equity (CDT) Stock Price, News & Analysis $0.44 -0.07 (-13.10%) Closing price 04:00 PM EasternExtended Trading$0.49 +0.05 (+10.56%) As of 04:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsSEC Filings About CDT Equity Stock (NASDAQ:CDT) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get CDT Equity alerts:Sign Up Key Stats Today's Range$0.44▼$0.5050-Day Range$0.51▼$455.0552-Week Range$0.44▼$302,487.50Volume404,788 shsAverage Volume258,137 shsMarket Capitalization$886.40P/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview CDT Equity, Inc. is a special purpose acquisition company (SPAC) formed to identify and complete a merger, share exchange, asset acquisition, or similar business combination with one or more operating businesses. As a SPAC, CDT Equity does not have significant commercial operations, products, or services of its own. Its principal activities generally consist of raising capital through a public offering, evaluating potential acquisition targets, and seeking shareholder approval for a proposed transaction. The company’s future business activities, geographic focus, and leadership structure will depend on any business combination it completes. No additional operating information is available without confirmation of a completed transaction.AI Generated. May Contain Errors. Read More CDT Equity Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks5th Percentile Overall ScoreCDT MarketRank™: 0.26642288102 of 5 starsCDT Equity scored higher than 5% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingCDT Equity has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageCDT Equity has only been the subject of 1 research reports in the past 90 days.Read more about CDT Equity's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of CDT Equity is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of CDT Equity is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted5,841.25% of the float of CDT Equity has been sold short.Short Interest Ratio / Days to CoverCDT Equity has a short interest ratio ("days to cover") of 0.01, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in CDT Equity has recently decreased by 9.79%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCDT Equity does not currently pay a dividend.Dividend GrowthCDT Equity does not have a long track record of dividend growth. News and Social Media1.2 / 5News Sentiment-0.04 News SentimentCDT Equity has a news sentiment score of -0.04. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.58 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 4 news articles for CDT Equity this week, compared to 3 articles on an average week. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, CDT Equity insiders have not sold or bought any company stock.Percentage Held by Insiders0.01% of the stock of CDT Equity is held by insiders.Percentage Held by Institutions3.29% of the stock of CDT Equity is held by institutions.Read more about CDT Equity's insider trading history. Receive CDT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CDT Equity and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CDT Stock News HeadlinesCDT Commences Human Skin Studies with QIMA Life Sciences on Novel Tapinarof Combinations in VitiligoNovember 11 at 7:00 AM | globenewswire.comCDT Equity Announces 1-for-20 Reverse Stock SplitNovember 4, 2026 | tipranks.comThis is likely to EXPLODEDr. Martin D. Weiss, founder of Weiss Ratings and a two-time Congressional witness on financial institution risk, is warning of a looming $3 trillion threat in today's financial system. He says the same ratings agency practices that preceded the 2008 crisis are repeating themselves, while regulators stay quiet about the risks.November 12 at 1:00 AM | Weiss Ratings (Ad)CDT Equity Welcomes U.S. Regulatory Development Supporting Expanded Access to Compounded PeptidesOctober 30, 2026 | globenewswire.comCDT Equity Inc. reports third quarter 2026 results and announces $100 million data center agreement for 2027October 29, 2026 | msn.comCDT Equity expands into animal health through Manoira dealOctober 27, 2026 | tipranks.comCDT Partners with Manoira to Explore Enhancing Animal Health Products Ahead of LaunchOctober 27, 2026 | globenewswire.comCDT Equity Inc Files Solid-Form Patent Application Covering Novel Solid Forms Of Major First-In-Class Respiratory MedicineOctober 14, 2026 | marketscreener.comMSee More Headlines CDT Stock Analysis - Frequently Asked Questions How have CDT shares performed this year? CDT Equity's stock was trading at $160,000.00 at the beginning of 2026. Since then, CDT shares have decreased by 100.0% and is now trading at $0.4530. How were CDT Equity's earnings last quarter? CDT Equity Inc. (NASDAQ:CDT) announced its quarterly earnings data on Wednesday, August, 12th. The company reported ($4,355.00) EPS for the quarter. When did CDT Equity's stock split? CDT Equity shares reverse split on Friday, March 27th 2026.The 1-25 reverse split was announced on Wednesday, March 25th 2026. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, March 26th 2026. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split. How do I buy shares of CDT Equity? Shares of CDT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of CDT Equity own? Based on aggregate information from My MarketBeat watchlists, some other companies that CDT Equity investors own include Tonix Pharmaceuticals (TNXP), Tempest Therapeutics (TPST), X4 Pharmaceuticals (XFOR), Immunic (IMUX), Invivyd (IVVD), Knightscope (KSCP) and AIM ImmunoTech (AIM). Company Calendar Last Earnings8/12/2026Today11/12/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (29m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 CDT's financial health is in the Red zone, according to TradeSmith. CDT has been in this zone for over 29 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNASDAQ:CDT Previous SymbolNASDAQ:CDT CIK1896212 Webwww.cdtequity.com Phone(646) 491-9132FaxN/AEmployees4Year FoundedN/AProfitability EPS (Trailing Twelve Months)($32,155.00) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$39.22 million Net MarginsN/A Pretax MarginN/A Return on Equity-72.25% Return on Assets-55.44% Debt Debt-to-Equity RatioN/A Current Ratio0.13 Quick Ratio0.13 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares2,000Free Float2,000Market Cap$898.00 OptionableNot Optionable Beta1.72 7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.Get This Free Report This page (NASDAQ:CDT) was last updated on 11/12/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredYour Social Security check is scheduled for a 22% cutThe U.S. now borrows money just to pay interest on money it already borrowed, a pattern economists call a debt...American Alternative | SponsoredSocial Security’s trust fund runs short in 2032. Guess who controls Congress.Social Security's retirement trust fund is projected to run dry in late 2032, per the 2026 Trustees Report. Af...Priority Gold | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMany investors are about to lose everythingTwenty five years ago, this analyst predicted the fiber optic boom and called Amazon before it became a househ...Porter & Company | SponsoredThis Could Be the Biggest Monetary Shift in 50 YearsThe U.S. government still values its gold reserves at $42 an ounce, a price set by Congress in 1973. Gold trad...Patriot Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CDT Equity Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CDT Equity With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
